EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin

Justyna Płonka-Czerw iD, Luiza Żyrek, Małgorzata Latocha iD

Molecules · 2024

DOI: 10.3390/molecules29153531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Justyna Płonka-Czerw und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jedności 8, 41-200 Sosnowiec, Poland. Hauptthemen laut MEDLINE: Metformin, Breast Neoplasms, Drug Resistance, Neoplasm, Doxorubicin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia in Katowice, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance is a serious problem in modern medicine and the reason for the failure of various therapies. A particularly important problem is the occurrence of multidrug resistance in cancer therapies which affects many cancer patients. Observations on the effect of metformin—a well-known hypoglycemic drug used in the treatment of type 2 diabetes—on cancer cells indicate the possibility of an interaction of this substance with drugs already used and, as a result, an increase in the sensitivity of cancer cells to cytostatics. The aim of this study was to evaluate the effect of metformin on the occurrence of multidrug resistance of breast cancer cells. The MCF-7-sensitive cell line and the MCF-7/DX cytostatic-resistant cell line were used for this study. WST-1 and LDH assays were used to evaluate the effects of metformin and doxorubicin on cell proliferation and viability. The effect of metformin on increasing the sensitivity of MCF-7 and MCF-7/DX cells to doxorubicin was evaluated in an MDR test. The participation of metformin in increasing the sensitivity of resistant cells to the effect of the cytostatic (doxorubicin) has been demonstrated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminBreast NeoplasmsDrug Resistance, NeoplasmDoxorubicinCell ProliferationCytostatic AgentsHumansMCF-7 CellsFemaleCell SurvivalDrug Resistance, MultipleHypoglycemic Agents

Stichwörter der Autor:innen

breast cancer cellscytostaticsdoxorubicinmetforminmultidrug resistance (MDR)

Substanzen

MetforminDoxorubicinCytostatic AgentsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jedności 8, 41-200 Sosnowiec, Poland.

ORCID-Profile: Justyna Płonka-Czerw, Małgorzata Latocha

Förderung

  • Medical University of Silesia in Katowice, Poland

Zitieren

APA

Płonka-Czerw, J., Żyrek, L., & Latocha, M. (2024). Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin. Molecules. https://doi.org/10.3390/molecules29153531

Vancouver

Płonka-Czerw J, Żyrek L, Latocha M. Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin. Molecules. 2024. doi:10.3390/molecules29153531

BibTeX
@article{PonkaCzerw2024,
  author = {Płonka-Czerw, Justyna and Żyrek, Luiza and Latocha, Małgorzata},
  title = {Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29153531}
}
Kostenlos starten →